Criteria for the control of drug-resistant tuberculosis.
about
Rifabutin for treating pulmonary tuberculosisTMC207: the first compound of a new class of potent anti-tuberculosis drugsEffects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West AfricaSlow elimination of multidrug-resistant tuberculosisAre survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation studyPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationThe Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesisIntegrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South AfricaCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisBayesian inference of infectious disease transmission from whole-genome sequence data.Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.Tuberculosis control and economic recession: longitudinal study of data from 21 European countries, 1991-2012Modeling the impact of tuberculosis control strategies in highly endemic overcrowded prisons.The impact of realistic age structure in simple models of tuberculosis transmission.Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, ChinaA mathematical study of a TB Model with treatment interruptions and two latent periods.Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon.The impact of HIV/AIDS on the control of tuberculosis in India.rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.Determinants of cluster distribution in the molecular epidemiology of tuberculosis.Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics.Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.The genetics of host resistance and susceptibility to tuberculosis.The burden of drug-resistant tuberculosis and mechanisms for its control.A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports.Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populationsPrevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study."Pros and cons" on how to measure multidrug resistance in leukemias.Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rateAverting epidemics of extensively drug-resistant tuberculosisMutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from ChinaThe epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.Models to understand the population-level impact of mixed strain M. tuberculosis infections.Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis.Eliminating human tuberculosis in the twenty-first century.Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern BrazilThe Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.
P2860
Q24242892-4F077C5E-C7BD-477F-A0C7-5E3AD6D4B834Q24632091-8EC668C7-46D9-402F-9FC4-61E28521EF55Q26742220-22BA4F76-F37C-4146-A769-7A3A9676FC36Q28278696-A2D54E51-487D-4364-9C54-3A07B3DA145FQ28472943-488DC5B7-06A7-4430-B382-EE32D94A7D5BQ28485280-CA955FEF-D6AA-4AB1-9751-FE39D7EAC1D7Q28486880-A52D2C4F-9893-4BDB-8A9E-5A0F879B0B75Q28547001-6DF6C472-6356-432F-93F4-4BD99B042D12Q28554655-15E005AD-800D-4631-89DB-FF05C6E7C1D6Q29247878-21A60F43-36D5-45F9-9BEC-0A66EBAD5AE1Q30796685-2BB9F0DE-83CD-4C5A-990D-9F3CB5E56838Q30830344-F6A6CD57-12DC-4E63-A78D-D7201307945BQ30984932-69C6AE8B-2860-4C54-AFDE-80EC87C3EAF1Q33332105-C817E07B-989D-4F3C-BDE6-46AB6939A751Q33523018-50A57030-C4CE-4B04-B299-3FAC07DC08BBQ33676299-63D33496-7863-4591-8A6A-C59E4C5F6178Q33746316-AECF11B3-FE40-4578-BFBC-020AD564F8A1Q33832822-2CC098C6-40FF-4254-8151-E37F2499F660Q33863432-48A26EEC-AD08-4A80-8799-A22EA20D3C6EQ33952004-BD1EED7F-C98F-45FA-AB05-78DCEC176317Q34010114-A53EAB3D-CBA8-4CC2-83B4-94D270733438Q34410451-6E49CEC1-0F2D-4752-A45D-579EE038E3E6Q34422228-02B58AE1-495D-48FC-A883-742FCFE71BB2Q34431677-A751FBCE-D8A9-4028-9D08-76A64F0CD572Q34497270-C2696B1D-89C0-45C2-B9C0-5CB27DDDCBF4Q34497340-744D1434-D640-489D-BB3B-39225A2A01DFQ34562609-6656F1CF-315C-45EA-9BDC-A1564E2D2AD1Q34598512-F36F2B56-2619-475E-A8F8-A534D4C8B1ACQ34707237-AE73A579-57C9-482C-9168-CD34411C4D9FQ34769843-6AB458C9-12AE-4C5A-850B-2F1A1377CEAAQ34975227-1E678D1D-07D1-4DE9-934A-1B4AB3EF0972Q34975537-88E321F3-C48D-4A35-8D5D-7E29CA11AB7BQ34990970-B428D094-2190-43A7-81EB-0D4FDCEA71BBQ34999398-99B31D8D-4DCE-4986-91F7-6A1463F52156Q35037192-54E7824B-9873-4BF4-ADC5-F816A81D8D0DQ35268889-3A9AD221-C255-4558-8CA6-BCF5BC4ED51AQ35581410-359E9514-2635-4DD7-8B11-127CC8D9CE44Q35584415-902F2DD0-1DC2-4BC6-BB3F-68490A5ADD55Q36059678-8E4FD361-5E4C-4F1D-BF27-E14A541D0DB6Q36094198-EE6C48A1-AB2E-4A2B-A538-6CA9F80F9802
P2860
Criteria for the control of drug-resistant tuberculosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Criteria for the control of drug-resistant tuberculosis.
@ast
Criteria for the control of drug-resistant tuberculosis.
@en
type
label
Criteria for the control of drug-resistant tuberculosis.
@ast
Criteria for the control of drug-resistant tuberculosis.
@en
prefLabel
Criteria for the control of drug-resistant tuberculosis.
@ast
Criteria for the control of drug-resistant tuberculosis.
@en
P2860
P356
P1476
Criteria for the control of drug-resistant tuberculosis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.140102797
P407
P577
2000-07-01T00:00:00Z